At least $259 in Medicaid payments tied to COVID-19 services reported in Manhasset in 2024

Dr. Mehmet Oz CMS Administrator
Dr. Mehmet Oz CMS Administrator
0Comments

At least $259 in Medicaid funds were paid out for services billed with HCPCS codes specifically linked to COVID-19 in Manhasset in 2024, data from the U.S. Department of Health and Human Services Medicaid Provider Spending database shows.

Medicaid is a government health insurance program administered by states and financed through federal and state funding. It provides coverage for low-income populations, seniors, children, and people with disabilities, making it a critical component of the nation’s health care sector.

Shifts in Medicaid billing locally reflect how taxpayer-backed healthcare resources are spent within the community.

This report identified COVID-19–specific services using HCPCS codes classified or referenced as “COVID-19” or “coronavirus” in claims or medical billing descriptors. Thus, the reported figures capture only those services clearly labeled as COVID-related, not pandemic-linked care billed with more general or indirectly related codes.

For context, Brooklyn had the state’s highest Medicaid payments for COVID-19–related services in 2024, totaling $3,718,101 based on claims for virus-associated HCPCS codes.

North Shore University Hospital was identified as the sole provider submitting COVID-19–related Medicaid claims in Manhasset for 2024, the data shows.

Throughout the pandemic, services designated specifically for COVID-19 represented a noticeable share of Medicaid spending growth in Manhasset.

Total Medicaid payments across all other categories rose by $1,542,419 from 2020 to 2024, reflecting a 10.5% increase.

Before the pandemic, the average annual Medicaid payout in Manhasset over the two years prior was $4,334,803.

According to the Centers for Medicare & Medicaid Services, total state and federal Medicaid expenditures reached about $871.7 billion for fiscal 2023, or roughly 18% of total U.S. health spend, sharply up from $613.5 billion spent in 2019, before the arrival of COVID-19.

This represents approximately 40% growth over a short period, mainly due to higher enrollment and increased utilization during and after the pandemic.

Recent federal budget policies under the Trump administration included major proposals to trim Medicaid funding and alter the program structure. The “One Big Beautiful Bill Act,” which became law in 2025, is expected to reduce federal Medicaid spending by more than $1 trillion over 10 years. The law introduces changes such as new work requirements and increased out-of-pocket costs that could reduce both funding and coverage for some enrollees, shifting more costs to states even as millions nationwide remain enrolled.

Medicaid Payments in Manhasset Over 7 Years
Year COVID-19–Related Payments COVID-19 Payments % Change (YoY) Total Medicaid Payments
2024 $259 -99.6% $16,291,007
2023 $65,114 -83.3% $22,039,502
2022 $390,888 -23.2% $20,635,196
2021 $508,986 130.1% $21,375,695
2020 $221,184 N/A $14,969,513
2019 $0 N/A $6,869,584
2018 $0 N/A $1,800,021
Top COVID-19–Related HCPCS Codes in Manhasset
HCPCS Code Description Medicaid Payments Claims
87635 COVID Specific $259 38

Note: Includes only HCPCS codes classified as COVID-19 services; figures do not include all pandemic-related care provided.

Data in this report was sourced from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Find the original data set here.



Related

Sean R. Keveney J.D., Chief Counsel of FDA

FDA inspects Swadesh Board USA, Inc. in Farmingdale on March 20, issues citation

On March 20, the FDA conducted an inspection at Swadesh Board USA, Inc. in Farmingdale for foodborne biological hazards and issued one violation.

Benjamin D. Moncarz Chief Financial Officer - FDA

FDA: 2 companies in cities within Nassau County received 4 citations in March

There were two companies in a city associated with Nassau County that received FDA citations as a result of two inspections conducted in the county in March, according to reports from the U.S. Food and Drug Administration (FDA).

Sara Brenner, Principal Deputy Commissioner at FDA

Swadesh Board USA, Inc. in Farmingdale inspected by FDA for biological hazards March 20

FDA records show that Swadesh Board USA, Inc. in Farmingdale underwent a March 20 inspection related to foodborne biological hazards.